Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Are Intra-Oral Scanners the Future of Dental Care?
Tech & Innovation Are Intra-Oral Scanners the Future of Dental Care?

The recent integration of intra-oral scanners at University College London Hospitals NHS Foundation Trust (UCLH) marks a transformative shift in dental care practices, highlighting a turning point in how dental health is approached in the United Kingdom. With their ability to offer precise and

Breakthrough DNA Therapy Offers New Hope for Ovarian Cancer
Research & Development Breakthrough DNA Therapy Offers New Hope for Ovarian Cancer

The world of oncology has been tirelessly searching for effective treatments against ovarian cancer, famously known as the deadliest of gynecological malignancies. This disease, notorious for its subtle symptoms and challenging early detection, often becomes evident only in its advanced stages,

Can New Diagnostic Tools Transform Autoimmune Treatment?
Research & Development Can New Diagnostic Tools Transform Autoimmune Treatment?

The medical world stands on the precipice of a groundbreaking shift, fueled by an unprecedented advancement in diagnostic tools that could revolutionize the treatment of autoimmune disorders. Conditions like rheumatoid arthritis have long presented significant challenges due to their complex nature

TB-500: Unlocking Potentials in Regeneration and Disease Modeling
Biotech & Bioprocessing TB-500: Unlocking Potentials in Regeneration and Disease Modeling

In recent years, the synthetic peptide TB-500, a counterpart to Thymosin Beta-4 (Tβ4), has garnered considerable interest for its promising role in various biological research applications. Its potential influence on tissue repair, inflammation modulation, and disease modeling has made it a subject

ANU Launches Center to Tackle Global Plant Biosecurity Issues
Biotech & Bioprocessing ANU Launches Center to Tackle Global Plant Biosecurity Issues

The Australian National University (ANU) has embarked on an ambitious journey addressing pressing global plant biosecurity challenges by inaugurating a groundbreaking ARC Training Center in Plant Biosecurity. This new initiative is geared toward preparing a new generation of scientists equipped to

Can AI Agents Revolutionize the Biopharma Workforce?
Research & Development Can AI Agents Revolutionize the Biopharma Workforce?

The biopharma industry stands on the brink of unprecedented transformation as AI agents promise to redefine how workforce dynamics unfold. Unlike traditional automation methods, AI agents utilize advanced natural language understanding, setting a new benchmark in automation technology. These

Can Compliance Culture Improve Mental Health in Law Firms?
Management & Regulatory Can Compliance Culture Improve Mental Health in Law Firms?

The legal profession is known for its demanding workload and tight deadlines, but there's another pressure simmering beneath the surface: compliance. With Mental Health Awareness Week approaching this May, it is crucial to recognize how a clearer compliance culture can alleviate stress and boost

VIA Disc NP: A New Hope for Chronic Back Pain Relief
Research & Development VIA Disc NP: A New Hope for Chronic Back Pain Relief

Countless individuals struggle with the debilitating condition of chronic lumbar discogenic pain, often resorting to invasive surgical procedures that can bring about complications and lengthy recovery periods. However, there is a beacon of hope on the horizon in the form of an innovative and

How Does Academic-Industry Synergy Boost CGT Advancements?
Biotech & Bioprocessing How Does Academic-Industry Synergy Boost CGT Advancements?

When it comes to the rapidly evolving field of cell and gene therapy (CGT), Ivan Kairatov stands out as a seasoned expert with significant insight into technological advances and strategic partnerships. His expertise is pivotal in understanding Matica Bio’s collaboration with Texas A&M’s National

DT-109: New Treatment for Heart and Liver Disease
Tech & Innovation DT-109: New Treatment for Heart and Liver Disease

In the rapidly evolving field of medical research, a new compound known as DT-109 has emerged as a beacon of hope for patients suffering from heart and liver diseases. Developed at the University of Michigan, this glycine-based compound was initially created to tackle metabolic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later